FARALLON CAPITAL MANAGEMENT, L.L.C.
Institutional investor · Portfolio as of Q4 2025
Top Holdings154 positions
STATE STR SPDR S&P 500 ETF T | 3M | $2B | 8.9% | — | — | — | Decreased — |
REVOLUTION MEDICINES INC | 14.6M | $1.2B | 5.0% | $35.31 | +125.56% | 20 qtrssince 2021-Q1 | Decreased 0 |
MICROSOFT | 2.2M | $1.1B | 4.6% | $338.48 | +41.98% | 29 qtrssince 2018-Q4 | Increased 67 |
AMAZON.COM | 4.5M | $1B | 4.5% | $221.93 | +4.00% | 3 qtrssince 2025-Q2 | Increased 73 |
<![CDATA[ELECTRONIC ARTS INC]]> | 5M | $1B | 4.5% | — | — | 1 qtr | New 88 |
AON PLC | 2.7M | $940.5M | 4.1% | $329.96 | +6.67% | 8 qtrssince 2024-Q1 | Increased 68 |
NATERA INC | 3.9M | $896.7M | 3.9% | $74.59 | +207.13% | 19 qtrssince 2021-Q2 | Decreased 0 |
BOSTON SCIENTIFIC CORP | 7.4M | $709.4M | 3.1% | $73.80 | +29.21% | 22 qtrssince 2020-Q3 | Increased 82 |
INVESCO EXCHANGE TRADED FD T | 3.6M | $689.6M | 3.0% | — | — | — | Decreased — |
EXELIXIS INC | 15.7M | $688.5M | 3.0% | $23.30 | +88.14% | 29 qtrssince 2018-Q4 | Decreased 0 |
BRIDGEBIO PHARMA INC COM | 9M | $688.3M | 3.0% | $37.26 | +105.30% | 6 qtrssince 2024-Q3 | Increased 60 |
EXACT SCIENCES CORP | 6.4M | $650.5M | 2.8% | — | — | 1 qtr | New 82 |
ISHARES TR | 8M | $645M | 2.8% | — | — | — | Decreased — |
PROTAGONIST THERAPEUTICS INC | 6.1M | $536.6M | 2.3% | $19.29 | +352.70% | 29 qtrssince 2018-Q4 | Decreased 0 |
WABTEC | 2.5M | $528.5M | 2.3% | $145.19 | +46.51% | 29 qtrssince 2018-Q4 | Increased 60 |
UNITEDHEALTH GROUP INC | 1.6M | $527.8M | 2.3% | $433.09 | -25.26% | 12 qtrssince 2023-Q1 | Decreased 0 |
CYBERARK SOFTWARE LTD | 1.1M | $469.7M | 2.0% | — | — | 1 qtr | New 81 |
WALT DISNEY | 4.1M | $469.4M | 2.0% | $96.90 | +16.52% | 7 qtrssince 2024-Q2 | Decreased 0 |
SYNOPSYS | 999,200 | $469.3M | 2.0% | $469.72 | 0.00% | 1 qtr | New 81 |
ELI LILLY & CO | 375,000 | $403M | 1.7% | — | — | — | Unchanged — |
FARALLON CAPITAL MANAGEMENT, L.L.C. manages $23.1B across 154 positions as of Q4 2025. Top holdings: SPY puts (8.9%), RVMD (5.0%), MSFT (4.6%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 1/5.0.
Active quarter - 30 new positions, 21 exits, 22 increased. Top move: EA (NEW, conviction 88). Portfolio: $23.1B across 154 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Famous Investors' Portfolios
What the most-followed managers hold, and what they bought and sold each quarter.
- Warren Buffett (Chairman Emeritus)Berkshire Hathaway
- Leopold AschenbrennerSituational Awareness
- Michael BurryScion Asset Management
- Cathie WoodARK Invest
- Bill AckmanPershing Square
- Stanley DruckenmillerDuquesne Family Office
- David TepperAppaloosa
- Ray Dalio (Founder)Bridgewater Associates
- Li LuHimalaya Capital
- Carl IcahnCarl C. Icahn
- Brad GerstnerAltimeter Capital
- Seth KlarmanThe Baupost Group
- Howard Marks (Co‑founder)Oaktree Capital Management
- Ken GriffinCitadel
- Paul Tudor JonesTudor Investment Corp
- George Soros (Founder)Soros Fund Management
- Steve CohenPoint72
- Terry SmithFundsmith
- Ken Fisher (Founder)Fisher Investments
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR